These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

390 related items for PubMed ID: 7694215

  • 1. Decreased alpha-fetoprotein in amniotic fluid and maternal serum in diabetic pregnancy.
    Henriques CU, Damm P, Tabor A, Pedersen JF, Mølsted-Pedersen L.
    Obstet Gynecol; 1993 Dec; 82(6):960-4. PubMed ID: 7694215
    [Abstract] [Full Text] [Related]

  • 2. Fetal oculocerebrorenal syndrome of Lowe associated with elevated maternal serum and amniotic fluid alpha-fetoprotein levels.
    Miller RC, Wolf EJ, Gould M, Macri CJ, Charnas LR.
    Obstet Gynecol; 1994 Jul; 84(1):77-80. PubMed ID: 7516514
    [Abstract] [Full Text] [Related]

  • 3. Biochemical screening for chromosomal disorders and neural tube defects (NTD): is adjustment of maternal alpha-fetoprotein (AFP) still appropriate in insulin-dependent diabetes mellitus (IDDM)?
    Sancken U, Bartels I.
    Prenat Diagn; 2001 May; 21(5):383-6. PubMed ID: 11360279
    [Abstract] [Full Text] [Related]

  • 4. Prognostic significance of unexplained elevated amniotic fluid alpha-fetoprotein.
    Wenstrom KD, Owen J, Davis RO, Brumfield CG.
    Obstet Gynecol; 1996 Feb; 87(2):213-6. PubMed ID: 8559526
    [Abstract] [Full Text] [Related]

  • 5. [Increased AFP in maternal serum as an indication for invasive diagnosis].
    Gremm B, Sohn C, Beldermann F, Bastert G.
    Zentralbl Gynakol; 1997 Feb; 119(11):560-6. PubMed ID: 9480612
    [Abstract] [Full Text] [Related]

  • 6. Elevated maternal serum alpha-fetoprotein and amniotic fluid alpha-fetoprotein after multifetal pregnancy reduction.
    Grau P, Robinson L, Tabsh K, Crandall BF.
    Obstet Gynecol; 1990 Dec; 76(6):1042-5. PubMed ID: 1700349
    [Abstract] [Full Text] [Related]

  • 7. Prenatal screening for congenital nephrosis in east Finland: results and impact on the birth prevalence of the disease.
    Heinonen S, Ryynänen M, Kirkinen P, Penttilä I, Syrjänen K, Seppälä M, Saarikoski S.
    Prenat Diagn; 1996 Mar; 16(3):207-13. PubMed ID: 8710773
    [Abstract] [Full Text] [Related]

  • 8. Combined ultrasonography and amniocentesis for pregnant women with elevated serum alpha-fetoprotein. Revising the risk estimate.
    Schell DL, Drugan A, Brindley BA, Zador IE, Johnson MP, Schwartz DB, Evans MI.
    J Reprod Med; 1990 May; 35(5):543-6. PubMed ID: 1693689
    [Abstract] [Full Text] [Related]

  • 9. Uterine malformation: a cause of elevated maternal serum alpha-fetoprotein concentrations.
    Heinonen S, Ryynänen M, Kirkinen P, Saarikoski S.
    Prenat Diagn; 1996 Jul; 16(7):635-9. PubMed ID: 8843473
    [Abstract] [Full Text] [Related]

  • 10. Abnormal maternal serum alpha fetoprotein and pregnancy outcome.
    Zarzour SJ, Gabert HA, Diket AL, St Amant M, Miller JM.
    J Matern Fetal Med; 1998 Jul; 7(6):304-7. PubMed ID: 9848697
    [Abstract] [Full Text] [Related]

  • 11. Alpha-fetoprotein in diabetic pregnancy. A reassessment.
    Tharakan T, Baxi L, Kramer D, Anderson R.
    J Reprod Med; 1993 Dec; 38(12):952-4. PubMed ID: 7509876
    [Abstract] [Full Text] [Related]

  • 12. Amniotic fluid alpha fetoprotein (AFAFP) and maternal serum alpha fetoprotein (MSAFP) in abdominal pregnancies: correlation with extent and site of placental implantation and clinical implications.
    Shumway JB, Greenspoon JS, Khouzami AN, Platt LD, Blakemore KJ.
    J Matern Fetal Med; 1996 Dec; 5(3):120-3. PubMed ID: 8796780
    [Abstract] [Full Text] [Related]

  • 13. Second-trimester maternal serum alpha-fetoprotein elevation and its association with adverse maternal/fetal outcome: ten years experience.
    Anfuso S, Soncini E, Bonelli P, Piantelli G, Gramellini D.
    Acta Biomed; 2007 Dec; 78(3):214-9. PubMed ID: 18330082
    [Abstract] [Full Text] [Related]

  • 14. Effect of adjustment of maternal serum alpha-fetoprotein levels in insulin-dependent diabetes mellitus.
    Kramer RL, Yaron Y, O'Brien JE, Critchfield G, Ayoub M, Johnson MP, Qualls CR, Evans MI.
    Am J Med Genet; 1998 Jan 13; 75(2):176-8. PubMed ID: 9450880
    [Abstract] [Full Text] [Related]

  • 15. Diagnostic use of meternal serum alpha-fetoprotein levels.
    Cowchock FS, Jackson LG.
    Obstet Gynecol; 1976 Jan 13; 47(1):63-8. PubMed ID: 54892
    [Abstract] [Full Text] [Related]

  • 16. [Association between amniotic fluid insulin in the second trimester, maternal glucose tolerance and fetal malformations].
    Bühling KJ, Mönnich J, Henrich W, Brauer M, Heinze T, Siebert G, Dudenhausen JW.
    Z Geburtshilfe Neonatol; 2004 Dec 13; 208(6):226-31. PubMed ID: 15647986
    [Abstract] [Full Text] [Related]

  • 17. [Maternal serum AFP screening in type I diabetic patients].
    Briese V.
    Zentralbl Gynakol; 1989 Dec 13; 111(10):664-8. PubMed ID: 2473582
    [Abstract] [Full Text] [Related]

  • 18. Unexplained elevations of maternal serum alpha-fetoprotein in women with antiphospholipid antibodies: a harbinger of fetal death.
    Silver RM, Draper ML, Byrne JL, Ashwood EA, Lyon JL, Branch DW.
    Obstet Gynecol; 1994 Jan 13; 83(1):150-5. PubMed ID: 7505912
    [Abstract] [Full Text] [Related]

  • 19. Routine assessment of amniotic fluid alpha-Fetoprotein in early second-trimester amniocentesis is no longer justified.
    Widlund KF, Gottvall T.
    Acta Obstet Gynecol Scand; 2007 Jan 13; 86(2):167-71. PubMed ID: 17364279
    [Abstract] [Full Text] [Related]

  • 20. Role of fetal sex in amniotic fluid alphafetoprotein screening.
    Knippel AJ.
    Prenat Diagn; 2002 Oct 13; 22(10):941-5. PubMed ID: 12378582
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.